Outlook Therapeutics, Inc. (OTLK) › Net IncomeOutlook Therapeutics, Inc. (OTLK) — Net IncomeAnnual figures by fiscal year, from SEC filings.2015: -$47.39M2016: -$53.30M2017: -$38.85M2018: -$30.09M2019: -$34.52M2020: -$35.24M2021: -$53.16M2022: -$66.05M2023: -$58.98M2024: -$75.37M2025: -$62.42M-$62.42M2015Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$62.42M+17.2%2024-$75.37M-27.8%2023-$58.98M+10.7%2022-$66.05M-24.2%2021-$53.16M-50.9%2020-$35.24M-2.1%2019-$34.52M-14.7%2018-$30.09M+22.5%2017-$38.85M+27.1%2016-$53.30M-12.5%2015-$47.39M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share